Phase 2 N=41 Study of BTK Inhibitor Zanubrutinib in Participants With Relapsed/Refractory Non-GCB Type Diffuse Large B Cell Lymphoma
Diffuse Large B-cell Lymphoma
Primary: Overall Response Rate — 29.3 percentage of participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=87 Chordate System Prophylactic Migraine Clinical Investigation
Migraine
Primary: Change From Baseline in Number of Migraine Days Per Four Weeks During the Three Months Post Treatment Investigation Duration — -1.5; -1.3 Migraine days/four weeks…
Phase 2 N=12 Dose Finding Safety Study of VAL201 in Cancer Patients
Stage III Prostate Carcinoma · Stage IV Prostate Carcinoma
Primary: Dose-Limiting Toxicity — 0; 0; 0; 0 Participants
N/A N=1,525 The Effect of Informative Letters on the Prescription and Receipt of Schedule II Controlled Substances
Economics · Fraud · Delivery of Health Care
Primary: 30-day Equivalent Prescribing of Schedule II Controlled Substances — 461.1; 450.0 30-day equivalent prescription fills
N/A N=10 Evaluation of Surface Refractive Index Shift of Kalifilcon A Lenses Compared to Dailies Total 1, Precision 1 and Biotrue ONEday Lenses
Habitual Soft Contact Lens Use
Primary: Surface Refractive Index Shifts at 5 Minutes — 1.4102; 1.4251; 1.4188; 1.3788 No units
N/A N=152 Adolescent Mindfulness Mobile App Study (RCT)
Rumination · Depression · Anxiety
Primary: Children's Response Styles Questionnaire — 33.47; 30.73 score on a scale
Phase 3 N=165 Study to Assess the Immune Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Taiwanese Adults 65 Years of Age and Older
Influenza (Healthy Volunteers)
Primary: Geometric Mean Titers (GMTs) of Influenza Vaccine Antibodies at Day 0 — 23.6; 24.1; 111; 169 titers
Phase 3 N=160 A Randomized Trial Evaluating Rapid Delivery of Dose Escalated Hypofractionated Radiotherapy for Patients Diagnosed With Bone Metastases for Effective Palliation of Symptoms
Bone Metastases
Primary: Number of Intent- to- Treat Patients With Pain Response by Treatment — 19; 34; 24; 36 Participants — p=.03
N/A N=40 Hybrid APC Assisted EMR for Large Colon Polyps
Colon Polyp · Colon Adenoma · Colon Cancer
Primary: Percentage of Participants Having Complete Resection — 40 Participants
N/A N=49 Tanglewood Trail Walking Program in Rural Kentucky 2020
Dietary Habits
Primary: Self-reported Fruit Intake — 2.2; 2.4 servings of fruit per day
N/A N=2,047 XIENCE 90: A Safety Evaluation of 3-month DAPT After XIENCE Implantation for HBR Patients.
Coronary Artery Lesions
Primary: Percentage of Participants With Composite Rate of All Death or All Myocardial Infarction (MI)(Modified Academic Research Consortium [ARC]), by Propensity Score Quintiles…
N/A N=36 Comparison of Nifedipine Versus Indomethacin for Acute Preterm Labor
Obstetric Labor, Premature
Primary: Number of Participants With Delay of Preterm Delivery by 48 Hours. — 15; 21 Participants
Phase 4 N=103 Evaluation of Abdominal Wall Block With Liposomal Bupivacaine for Post-Operative Analgesia in Donor Nephrectomy
Pain, Postoperative · Analgesics, Opioid · Analgesics, Non-Narcotic
Primary: Change in Pain Score — 4.20; 4.62 score on a scale
N/A N=44 F&P Toffee Full Face Mask Clinical Trial, NZ, 2020
Positive Airway Pressure Therapy · Obstructive Sleep Apnea
Primary: Comfort - Subjective — 18; 23; 2; 1 Participants
N/A N=122 Waiting Room's Environment and Children Anxiety Prior Dental Treatment
Dental Anxiety
Primary: Dental Anxiety — 1.71; 2 units on a scale